|
시장보고서
상품코드
1663813
스파이로미터 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 메커니즘별, 질환별, 일회용 부품별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)Spirometer Market Size, Share, and Growth Analysis, By Product Type, By Technology, By Mechanism, By Disease, By Disposable Components, By Application, By End-User, By Distribution Channel, By Region - Industry Forecast 2025-2032 |
||||||
스파이로미터 시장 규모는 2023년에 12억 달러로, 2024년 13억 1,000만 달러에서 2032년에는 26억 9,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 9.4%로 성장할 전망입니다.
만성 호흡기 질환의 유병률 증가, 홈케어에 대한 소비자의 선호도 변화, 기술 발전 등을 배경으로 호흡기 측정 기기 시장은 크게 성장할 것으로 전망됩니다. 세계보건기구(WHO)의 보고에 따르면 세계 인구의 90%가 열악한 공기에 노출되어 폐 건강 문제를 악화시키고 있습니다. 만성폐쇄성폐질환(COPD)의 발병률이 증가함에 따라 특히 유럽과 같은 지역에서는 2050년까지 COPD 환자가 크게 증가할 것으로 예상에 따라 폐활량계 검사에 대한 수요는 계속 증가할 것으로 예상됩니다. 또한 고령화로 인해 호흡기 질환에 걸리기 쉬워지면서 효과적인 진단 툴의 필요성이 더욱 커지고 있습니다. 휴대성 및 스마트 기기 연결을 포함한 폐활량계 설계의 혁신은 환자 모니터링을 강화하고 시장 확대를 촉진하고 있습니다.
Spirometer Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.31 billion in 2024 to USD 2.69 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).
The market for spirometry equipment is poised for significant growth, driven by the increased prevalence of chronic respiratory diseases, evolving consumer preferences for home care, and advancements in technology. The World Health Organization (WHO) reports that 90% of the global population is exposed to poor air quality, exacerbating lung health issues. As the incidence of Chronic Obstructive Pulmonary Disease (COPD) rises, the demand for spirometry tests will continue to escalate, particularly in regions like Europe, where projections indicate a substantial increase in COPD cases by 2050. Additionally, an aging population is more susceptible to respiratory conditions, further fueling the need for effective diagnostic tools. Innovations in spirometry design, including portability and smart device connectivity, are enhancing patient monitoring and promoting market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Spirometer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Spirometer Market Segments Analysis
Global Spirometer Market is segmented by Product Type, Technology, Mechanism, Disease, Disposable Components, Application, End-User, Distribution Channel and region. Based on Product Type, the market is segmented into Software, Devices and Consumables and Accessories. Based on Technology, the market is segmented into Volume Measurement Spirometer, Flow Measurement Spirometer and Peak Flow Meter. Based on Mechanism, the market is segmented into Flow-Sensing Spirometer and Peak Flow Meters. Based on Disease, the market is segmented into Bronchitis, Emphysema, Chronic Obstructive Lung Disease, Lung Cancer and Others. Based on Disposable Components, the market is segmented into Filters, Sensors and Tubes. Based on Application, the market is segmented into Asthma, COPD,Cystic Fibrosis, Pulmonary Fibrosis and Others. Based on End-User, the market is segmented into Hospitals, Clinics and Homecare. Based on Distribution Channel, the market is segmented into Over the Counter and Direct Tender. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Spirometer Market
The spirometer market is primarily driven by the urgent need for early diagnosis, effective disease management, and timely treatment for individuals suffering from respiratory disorders. In 2020, chronic obstructive pulmonary disease (COPD) was estimated to affect 10.6% of the global population-approximately 480 million individuals. Projections indicate that the number of COPD cases could surge by 112 million by 2050, bringing the total to around 592 million, or 9.3% of the population. This substantial increase is particularly notable among female patients and in low- and middle-income countries (LMICs). Specifically, COPD prevalence in women is expected to rise from 7.8% to 8.3% between 2020 and 2050, while the population aged 65 and above is also anticipated to grow, thereby heightening the demand for spirometry devices.
Restraints in the Spirometer Market
The Spirometer market is witnessing significant expansion driven by an increasing emphasis on public health and respiratory disease screening by governments globally. In October 2021, for example, the Chinese government launched a nationwide COPD screening initiative targeting 800,000 individuals aged 35-75, highlighting the critical role of spirometry in diagnosing chronic respiratory conditions. Similarly, India is undergoing a shift in disease burden from communicable to non-communicable diseases, including chronic respiratory illnesses, contributing to high mortality rates. This growing prevalence underlines the necessity for efficient diagnostic tools like spirometers, creating substantial opportunities for stakeholders and positioning spirometry as an essential instrument in combating respiratory diseases worldwide.
Market Trends of the Spirometer Market
The global spirometer market is witnessing significant growth fueled by advancements in technology that prioritize user-friendliness, portability, and affordability. Enhanced designs, such as the emergence of portable spirometry devices, have revolutionized respiratory care by facilitating pulmonary function tests outside traditional healthcare settings, notably in point-of-care and telemedicine environments. The FDA approval of innovative solutions like NuvoAir's Air Next spirometer for home use exemplifies this trend. Furthermore, the integration of spirometers with smartphone applications is becoming commonplace, enabling real-time tracking of respiratory health and seamless data sharing with healthcare providers, reinforcing the trend towards personalized, accessible healthcare solutions.